Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9650411 | 0.84 | ACHE (0.34) | — | |
| SCHEMBL9648522 | 0.72 | TSHR (0.31) | — | |
| SCHEMBL9650425 | 0.71 | CHRNB4 (0.35) | NPC1RAB9A | |
| SCHEMBL17135804 | 0.62 | ACHE (0.37) | NPC1RAB9A | |
| SCHEMBL197346 | 0.61 | BCL2L1 (0.55) | NPC1RAB9A | |
| SCHEMBL10300262 | 0.61 | BCL2L1 (0.55) | NPC1RAB9A | |
| SCHEMBL10337645 | 0.61 | BCL2L1 (0.55) | NPC1RAB9A | |
| SCHEMBL12562793 | 0.61 | BCL2L1 (0.55) | NPC1RAB9A | |
| SCHEMBL4599704 | 0.61 | — | — | |
| SCHEMBL2546251 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9422282-B2 | Compounds and method for treatment of HIV | CRITICAL OUTCOME TECHNOLOGIES INC. (CA) | 2016-08-23 | — | — | US | disclosed |
| US-20150183782-A1 | COMPOUNDS AND METHOD FOR TREATMENT OF HIV | MORGAN STANLEY SENIOR FUNDING, INC. | 2015-07-02 | — | — | US | disclosed |
| US-8987272-B2 | Compounds and method for treatment of HIV | CRITICAL OUTCOME TECHNOLOGIES INC. (CA) | 2015-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150183782-A1 | COMPOUNDS AND METHOD FOR TREATMENT OF HIV | NNT, CCR5, XDH | NPC1 21/4885RAB9A 3745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.